Full-Time

Localization QA Tester / Proofreader

Posted on 9/26/2025

Deadline 10/31/25
Welocalize

Welocalize

5,001-10,000 employees

AI-powered content localization platform and services

No salary listed

Austin, TX, USA

In Person

Must be onsite; visa required to work in USA.

Category
QA & Testing (2)
,
Required Skills
iOS/Swift
Requirements
  • Native-level fluency in their respective language (grammar, vocabulary, composition, punctuation)
  • Fluency in English (written and spoken)
  • Experience working in translation
  • Tech savvy, with experience testing web-based systems and applications on Mac OS X and iOS
  • Ability to prioritize linguistic issues and distinguish between a true must-fix and a nice-to-have
  • Experience working with test cases and test scripts
  • Experience with bug tracking systems
  • Ability to clearly articulate reproduction steps for a given issue and communicate critical information
  • Strong problem-solving skills
  • Ability to work independently and as part of a team
  • Ability to work with a very diverse team
  • Flexibility to work during non-business hours, weekends, and national/federal holidays
  • Ability to work under pressure in a fast-paced environment
  • Strong team ethic
  • Austin, TX (100% onsite, no remote work)
  • W-2 (eligible for benefits based on hours worked)
  • Monday-Friday (set hours)
  • You must have a valid visa to work in the USA
  • Languages needed: Multiple
Responsibilities
  • Proofread and edit content already localized to your native language, catching errors in grammar, typos, syntax, punctuation, capitalization, political incorrectness, inconsistencies, and extra spaces between words or characters
  • Sometimes translate content from English to native language
  • Check UIs for functional issues
  • Test a wide range of internally and externally facing applications and tools
  • Conduct test cases, identify localization bugs, report them via an internal bug tracking system, and verify fixes once implemented

Welocalize helps global brands reach international audiences by localizing content for different languages and cultures. Its product, OPAL, is an AI-enabled service platform that streamlines translation, review, and approval using modular AI blocks, connectors to enterprise systems, and workflow apps. This integrated approach combines automation with human review to speed delivery, reduce costs, and improve accuracy. The company aims to help clients expand globally, boost engagement with international customers, and grow revenue through scalable localization.

Company Size

5,001-10,000

Company Stage

Growth Equity (Venture Capital)

Total Funding

$34M

Headquarters

New York City, New York

Founded

1997

Simplify Jobs

Simplify's Take

What believers are saying

  • Clinical trials market demands linguistic validation, creating recurring high-margin service opportunities.
  • Paul Danter's appointment signals strategic focus on premium-priced technology and entertainment verticals.
  • PATHFINDER e-learning platform builds brand authority in rapidly growing AI-enabled language services sector.

What critics are saying

  • EU AI Act enforcement fines up to €35M or 7% global turnover for non-transparent OPAL NMT disclosures.[1][3]
  • OpenAI enterprise localization API enables in-house translation at 70% lower cost for top clients.[1]
  • RWS Smartling MT integration offers half OPAL implementation time, capturing workflow automation clients.[1]

What makes Welocalize unique

  • AILQA Beta and TranslationRater™ embed quality assurance directly into enterprise AI workflows.
  • Next Level Globalization acquisition strengthens life sciences division with specialized medical devices expertise.
  • Ranked among world's largest LSPs by CSA Research, Nimdzi, and Slator with 400+ employees.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Accident Insurance

Critical Illness Insurance

Hospital Indemnity Insurance

Telemedicine Benefit

Paid Sick Time

Paid Holidays

Employee Assistance Program

Mileage Reimbursement

Medical Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Voluntary Life Insurance

401(k) Retirement Plan

Growth & Insights and Company News

Headcount

6 month growth

5%

1 year growth

2%

2 year growth

8%
Welocalize
Jul 17th, 2025
AILQA Wins "Natural Language Recognition Solution of the Year" at AI Breakthrough Awards

Welocalize's AI-Led Quality Assurance (AILQA) solution has been named "Natural Language Recognition Solution of the Year" in the 2025 AI Breakthrough Awards, celebrating a major milestone in redefining multilingual content quality at scale.

Norwest Equity Partners
May 14th, 2025
Welocalize Celebrates its 19th Acquisition as Next Level Globalization Joins - Norwest Equity PartnersNorwest Equity Partners

The following press release was issued by our portfolio company, Welocalize:  Germany-based NLG adds deep medical devices and diagnostics language services experience to Welocalize’s life sciences division. NEW YORK and MUNICH— Welocalize, ranked as one of the world’s largest LSPs by language industry intelligence firms CSA Research, Nimdzi, and Slator, announces the acquisition of Next […]

Slator AG
Mar 20th, 2025
Welocalize Launches AILQA Beta Program to Enhance AI-Powered Translation Quality Assessment

Welocalize launches AILQA Beta program to enhance ai-powered Translation Quality assessment.

EIN Presswire
Jan 9th, 2025
Welocalize Appoints Paul Danter as General Manager of Technology, Manufacturing, and Entertainment Division

NEW YORK, NY, UNITED STATES, January 9, 2025 /EINPresswire.com/ - Welocalize, a global leader in language services and AI-driven solutions, today announced the appointment of Paul Danter as General Manager of its Technology, Manufacturing, and Entertainment division.

PharmaVoice
Nov 25th, 2024
Driving Accuracy in Clinical Trials with Welocalize's Guide to Linguistic Validation

Welocalize, a global leader in AI-enabled language and content services, has released a new white paper titled "Beyond Translation: Linguistic Validation for Clinical Outcome Assessments."

INACTIVE